Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today announced ...

HSSC CET Phase 2 recruitment 2026: The Haryana Staff Selection Commission (HSSC) has started the online registration process for the Common Eligibility Test (CET) Phase-II under Advt. No. 04/2026.

Crystalline polymers assembled inside tumor cell lysosomes rupture membranes, release iron, and trigger immune-activating ...

Attosecond pulses enable sub-femtosecond studies of ultrafast electron dynamics. Since 2001, pulse durations have shortened ...

Add Yahoo as a preferred source to see more of our stories on Google. Nearly two years after breaking ground, the Catawba Two Kings Casino is taking shape off Interstate 85, about 35 miles from ...

"This simply sets us up so if there is anything now or in the future, that we can get recouped." ...

From advanced nickel alloys to subsea monitoring systems, this article examines how materials science, surface engineering, ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...